Growth Marketing Studios
The Direct Answer, the Real Risks, and a Safer Tracking Architecture for Medical Practices
In this article:
This guide explains why Google Analytics 4 is not a HIPAA-compliant service, when healthcare website tracking may expose protected health information, and how medical practices can reduce risk through data minimization, server-side controls, vendor agreements, consent management, and ongoing audits. It also examines Meta Pixel, CRM integrations, Florida’s FIPA requirements, and the practical steps practices should take before sending another event to GA4.
No. Google Analytics 4 is not a HIPAA-compliant service for receiving or processing protected health information, and Google does not offer a Business Associate Agreement for Google Analytics.
That does not necessarily mean every medical practice must remove GA4 from every public page. It means the practice must prevent protected health information from reaching Google in the first place.
Google’s position is direct: HIPAA-regulated organizations must not use Analytics in any way that implicates Google’s access to, or collection of, PHI. Google also advises covered organizations to avoid placing Analytics tags on authenticated pages and other pages that may be connected to the provision of healthcare services.
The practical question is not whether someone enabled the right privacy setting inside GA4.
It is: what information leaves the website, who receives it, and has anything sensitive been removed before that disclosure occurs?
At Growth Marketing Studios, we do not evaluate GA4 as an isolated tag. We look at the entire path from the visitor’s browser to the practice’s analytics property, advertising accounts, forms, scheduling software, call-tracking provider, CRM, and patient-facing systems.
A clean-looking GA4 dashboard tells us very little about whether the underlying data flow is safe.
GA4 can measure pageviews, traffic sources, engagement, button clicks, and conversion events. Those capabilities are useful to medical practices, hospitals, plastic surgery clinics, dental offices, and other healthcare organizations.
The risk begins when an event includes information that identifies, or can reasonably be connected to, an individual and also relates to that person’s health, healthcare, or payment for healthcare.
An event called appointment_requested may look harmless. It becomes far more sensitive when the same request includes:
HIPAA compliance is not determined by the label displayed in a GA4 report. It depends on what was collected, what was transmitted, why it was transmitted, and what the receiving vendor could access.
A Business Associate Agreement is not a generic privacy certificate. It is a contract governing how a business associate may create, receive, maintain, or transmit PHI on behalf of a HIPAA-regulated entity.
Google explicitly states that it does not offer a BAA in connection with Google Analytics and makes no representation that Analytics satisfies HIPAA requirements.
That removes a route that would otherwise be considered when a vendor needs access to PHI to perform a covered function.
A healthcare organization should therefore design its GA4 implementation so Google never receives PHI.
This is also why the phrase “make GA4 HIPAA compliant” can be misleading.
A practice may be able to create a data flow that sends only approved, non-PHI data to GA4. That does not turn Google Analytics into a HIPAA-covered system. It means the practice has attempted to keep regulated information outside the service.
The difference matters.
“GA4 is now compliant” suggests the platform can safely receive PHI.
“Our implementation prevents PHI from reaching GA4” describes the control that actually needs to exist.
A medical practice might use GA4 on a careers page, a page listing office hours, or another general-information page where the event does not reveal anything about an individual’s healthcare.
The same practice may need to block GA4 from:
Current HHS guidance distinguishes between authenticated pages, which generally have access to PHI, and unauthenticated pages, which require a more fact-specific analysis. A public page about job openings or visiting hours may not involve PHI, while an appointment form, symptom tool, portal registration page, or authenticated patient area can expose identifiable healthcare information.
There is no single GA4 switch that can classify those pages correctly.
Someone has to map the website, inspect what fires, review the data attached to each event, and decide which destinations are permitted to receive it.
Tracking becomes a HIPAA concern when a regulated organization’s website or app discloses PHI to a technology vendor or uses tracking technologies in another way that conflicts with the HIPAA Rules.
The word discloses matters.
Many marketing teams focus on what eventually appears inside a report. The relevant transmission may happen earlier, when the browser sends a network request to Google, Meta, a call-tracking provider, a form platform, or another third party.
Deleting a field later does not undo the original transmission.
HHS says tracking technologies can collect information entered or selected by a user, appointment details, email addresses, device identifiers, IP addresses, geographic data, medical record numbers, and other unique codes. Whether that information qualifies as PHI depends on the identity, context, relationship, and purpose involved.
Most practice owners understand that a form containing a patient’s name and medical concern deserves protection.
Fewer realize how much information can leak around the form.
One of the first places we check is the URL.
Consider a consultation flow that redirects a visitor to:
/thank-you/?procedure=breast-reconstruction&email=jane@example.com
Even when the GA4 tag is not intentionally configured to collect form values, the complete page location may be captured. Advertising pixels, session-recording tools, embedded widgets, and other scripts may read the same URL.
Sensitive information can also appear in:
Google provides a GA4 data-redaction feature for likely email addresses and selected URL query parameters. That can be a useful secondary safeguard, but Google describes email detection as a best-effort feature and notes that redaction does not cover every collection method, including Measurement Protocol and Data Import.
A healthcare tracking strategy should not depend on a pattern-matching tool catching every identifier, procedure name, diagnosis, symptom, or free-text entry.
A useful review starts by dividing the website into functional areas.
A page listing office hours may disclose nothing about a visitor’s healthcare. An appointment page may reveal that a named person is requesting a particular service. A patient portal may expose diagnoses, prescriptions, billing records, medical record numbers, or appointment details.
HHS states that tracking technologies on authenticated pages generally have access to PHI. It also explains that many unauthenticated pages may fall outside HIPAA when the technologies do not receive information related to an individual’s health, healthcare, or payment for healthcare.
There is an important nuance for public service pages.
An IP address combined with a visit to a webpage about a medical condition is not automatically PHI in every situation. The visit must also relate to the individual’s past, present, or future health, healthcare, or payment for healthcare. HHS uses the example of a student researching oncology services versus a person visiting the same page to seek a second opinion for a brain tumor.
That does not make procedure pages risk-free.
It means blanket claims such as “every visit to every healthcare page is always PHI” are too broad. The organization still needs a defensible method for deciding which pages and events create a healthcare-related disclosure.
The event name itself may disclose health-related information.
Examples that deserve immediate review include:
fertility_consultation_startedaddiction_treatment_form_completedbreast_reconstruction_leadgender_affirming_care_requestoncology_second_opinionmental_health_appointment
Replacing one of those names with generate_lead may reduce the obvious disclosure, but renaming alone does not solve the problem.
The page path, event parameters, browser identifiers, query strings, ad-click IDs, form values, and downstream CRM data can still reveal the context.
We review the complete request, not only the field that appears in the standard GA4 event report.
That means looking at:
Potentially, but only where the implementation prevents PHI from reaching Google.
That is a much narrower answer than saying GA4 is compliant.
A practice might use GA4 for limited traffic measurement on clearly non-covered pages while disabling it entirely on appointment flows, consultation forms, patient portals, login pages, and other sensitive surfaces.
Another practice might route a small set of approved events through a controlled server-side layer that removes prohibited fields before the event reaches GA4.
The correct design depends on:
The type of organization
Whether it is a HIPAA-regulated entity
The purpose of the page
The information collected
The identifiers attached to the event
The first vendor receiving the information
The downstream destinations
The contracts in place
The method used to filter or de-identify data
A technical audit can identify what the system actually transmits. Legal counsel should determine how the organization’s specific obligations apply.
A limited measurement plan may include events that do not identify a person or reveal health-related activity, such as:
Even these examples are not automatic safe harbors.
A generic page_view can still include a revealing URL. A navigation click can include procedure-specific button text. A campaign event can be enriched later by an unsafe CRM integration.
The words “anonymous” and “aggregated” are not enough. The request has to be inspected.
GA4 should not receive PHI, including data such as:
| Data category | Examples |
|---|---|
| Direct identifiers | Names, email addresses, phone numbers, home addresses |
| Medical identifiers | Patient IDs, medical record numbers, insurance identifiers |
| Health information | Diagnoses, symptoms, treatments, prescriptions |
| Appointment details | Dates, providers, reasons for the visit |
| Sensitive form content | Medical concerns, intake answers, uploaded images |
| Revealing URLs | Paths or parameters connecting a person to care |
| Identifiable CRM data | Lead records establishing a patient relationship |
| Portal information | Login data, account details, billing or treatment information |
Google also prohibits customers from sending data Google can recognize as personally identifiable information. HIPAA-regulated organizations face the additional requirement not to expose PHI to Google Analytics.
Marketing value does not change the nature of the information.
GA4’s treatment of IP addresses does not resolve the whole HIPAA question.
Other identifiers and event details can still expose sensitive context, including:
The same limitation applies to other partial fixes:
Privacy settings are worth using.
They are not a substitute for controlling the information before it leaves the environment.
No. Server-side tracking does not automatically make Google Analytics 4 HIPAA compliant.
It can give a medical practice more control over what leaves the browser and which platforms receive each event. That makes it useful.
But a server container is a control layer, not a compliance certificate.
A poorly designed server-side setup can forward the same unsafe information as a browser tag. It may simply move the problem to another location.
The deeper technical implementation belongs in Server-Side Tracking for Medical Practices. The key distinction here is what the server layer can and cannot accomplish.
A properly designed architecture may allow the organization to:
The most important word is before.
Filtering has to occur before unapproved information reaches the downstream platform.
HHS describes an architecture in which an appropriately contracted vendor may receive tracking data containing PHI, de-identify it, and then disclose only de-identified information to a downstream tracking vendor that will not enter into a BAA.
A server-side tagging environment may form part of that architecture, but the hosting provider, vendor contracts, transformation rules, access controls, and de-identification method still need to be reviewed.
A server container cannot repair:
Server-side tracking is not automatically private, first-party, de-identified, or HIPAA-safe because a request passes through a domain owned by the practice.
The system has to earn those descriptions through its actual behavior.
This is one of the most important distinctions in the entire setup.
HHS says it is insufficient for a tracking vendor to receive PHI and then promise to remove or de-identify the data before storing it. If the vendor has already received PHI, the disclosure has already occurred.
A safer flow looks like this:
Website or application
↓
Controlled, appropriately contracted environment
↓
Validation, minimization, filtering, or de-identification
↓
Approved non-PHI event
↓
Google Analytics 4It should not look like this:
Website or application
↓
GA4 receives the complete event
↓
A setting, deletion request, or vendor promise removes data laterThe order of operations changes the risk.
A visual comparison makes the difference easier to see.
A common healthcare marketing setup looks like this:
Visitor ↓ Practice website ├── Google Analytics 4 ├── Google Ads ├── Meta Pixel ├── Call-tracking software ├── Scheduling widget ├── CRM ├── Chat platform └── Session replay
Each destination may receive information directly from the browser. Different scripts can read the same page, cookies, forms, URLs, button labels, and identifiers.
The marketing team may know which tags were installed without knowing everything those tags transmit.
That is where the risk often hides: not in the list of tools, but in the gaps between them.
A practice can invest heavily in SEO, paid search, and social advertising while a pixel continues to fire on a consultation form or procedure-specific confirmation page. The problem is rarely that nobody cares about compliance. It is that nobody has been assigned responsibility for the full path between the website, the tracking platform, and the patient inquiry.
The wider compliance framework is covered in our HIPAA Compliance in 2026 guide.
A more defensible model separates sensitive operations from general measurement:
Visitor ↓ Practice website ↓ Controlled collection layer ├── Sensitive information → Approved BAA-covered system ├── Approved CRM fields → Healthcare workflow ├── De-identified event → GA4 ├── Restricted signal → Approved advertising destination └── Audit log → Internal review
The controlled layer should work from an allowlist, not a wish list.
Instead of collecting everything and trying to remove unsafe fields later, the system should forward only fields that have been reviewed and approved.
GA4 may need to know that a permitted conversion occurred. It does not need the person’s name, phone number, procedure selection, appointment date, medical concern, form message, or internal patient record.
The more specific the signal becomes, the harder it is to defend the position that the event reveals nothing about an individual’s healthcare activity.
A BAA is generally required when a vendor meets the definition of a business associate by creating, receiving, maintaining, or transmitting PHI on behalf of a covered entity for a covered function or service.
HHS says a business associate contract must define permitted uses and disclosures, require safeguards, address incident reporting, control subcontractors, and include other protections.
Signing a BAA does not excuse unnecessary collection.
The absence of a BAA cannot be fixed with a privacy-policy update.
A controlled architecture also needs:
HHS expects regulated organizations to include tracking technologies in their risk-analysis and risk-management processes and to apply appropriate administrative, physical, and technical safeguards.
The architecture has to work after someone publishes a new landing page, changes a form, or adds a conversion tag, not only on the day the original setup was approved.
A BAA is generally required when a vendor meets the definition of a business associate by creating, receiving, maintaining, or transmitting PHI on behalf of a covered entity for a covered function or service.
HHS says a business associate contract must define permitted uses and disclosures, require safeguards, address incident reporting, control subcontractors, and include other protections.
Signing a BAA does not excuse unnecessary collection.
The absence of a BAA cannot be fixed with a privacy-policy update.
A controlled architecture also needs:
HHS expects regulated organizations to include tracking technologies in their risk-analysis and risk-management processes and to apply appropriate administrative, physical, and technical safeguards.
The architecture has to work after someone publishes a new landing page, changes a form, or adds a conversion tag, not only on the day the original setup was approved.
Removing GA4 can eliminate one source of exposure.
It does not make the rest of the website compliant.
A practice may disable Analytics and continue sending sensitive information through:
HHS guidance applies to tracking technologies broadly, including cookies, pixels, web beacons, session-replay scripts, fingerprinting tools, and similar technologies.
The risk analysis has to cover the entire stack.
Meta Pixel can receive page context, custom events, URLs, identifiers, and conversion activity.
The same practical question applies:
Does this event tell the platform something identifiable about a person’s health or healthcare activity?
A generic homepage visit and a completed addiction-treatment intake are not equivalent events.
Medical advertisers also need to review:
The desire to improve advertising performance does not authorize the disclosure of PHI.
That is why “remove GA4” is not a complete remediation plan. Every outbound request and advertising destination needs to be evaluated separately.
Appointment requests are among the clearest high-risk areas.
HHS gives the example of a person scheduling healthcare services through a covered clinic’s website. When the site transmits appointment information and an identifier such as an IP address to a tracking vendor, that vendor may be a business associate and a BAA may be required.
The form is only one layer.
The practice should also inspect:
A form may use encryption in transit and still create risk if its contents are copied into a standard email inbox, analytics platform, or marketing CRM without appropriate controls.
A clean GA4 setup can sit beside an unsafe form-to-CRM workflow.
Both systems need to be reviewed together.
The CRM may contain:
Sending that record back to Google Ads or Meta for optimization can create a new disclosure even if the original website event was limited.
Offline conversion programs deserve particular attention because they intentionally connect marketing identifiers with later business outcomes.
A practice may want to distinguish between:
That attribution is commercially valuable. It can also create a much stronger connection between an advertising identifier and a person’s healthcare activity.
The safer design asks whether the same business insight can be produced without sending patient-level health information to an advertising platform. That is the reporting problem we solve inside controlled systems with data analytics in plastic surgery.
Plastic surgery practices face additional complexity because procedure pages, consultation forms, financing workflows, and before-and-after galleries can reveal unusually specific intent. That specialty workflow belongs in HIPAA-Compliant Marketing for Plastic Surgery Clinics.
A cookie banner may help control when tracking scripts load. It may also support obligations under state privacy laws and other frameworks.
It is not automatically a valid HIPAA authorization.
HHS states that website banners asking users to accept or reject tracking technologies such as cookies do not constitute a HIPAA-compliant authorization. A privacy policy or terms-of-use notice also does not, by itself, permit the disclosure of PHI to a tracking vendor.
That distinction matters because many healthcare websites display language such as:
By continuing to use this website, you agree to our use of cookies.
That sentence does not transform an otherwise impermissible disclosure into a permissible one.
A consent management platform may help a practice:
Those controls are useful.
Google Consent Mode can modify how Google tags behave based on consent signals. It does not determine whether an event contains PHI, whether a disclosure is permitted, or whether a BAA is required.
A consent platform controls tag behavior.
It does not perform the entire legal, contractual, and data-classification analysis.
A standard cookie banner cannot repair:
The consent layer is one part of the architecture.
Treating it as the whole answer can produce a website that looks privacy-conscious while its network requests remain unchanged.
When a vendor creates, receives, maintains, or transmits PHI on behalf of a regulated entity and meets the definition of a business associate, the organization generally needs an appropriate BAA and a permitted basis for the disclosure.
A BAA should specify permitted uses, disclosure restrictions, safeguards, incident-reporting duties, subcontractor requirements, and what happens when the relationship ends.
For every vendor in the stack, we ask:
The answers should be documented, not assumed.
Florida medical practices have a state-law layer to consider alongside HIPAA.
Florida Statute 501.171, commonly associated with the Florida Information Protection Act, requires covered entities and third-party agents to take reasonable measures to protect electronic personal information.
The statutory definition of personal information includes a person’s name combined with certain data elements, including medical history, mental or physical condition, medical treatment, diagnosis, health-insurance identifiers, biometric information, and geolocation.
That does not mean every GA4 event automatically creates a reportable FIPA breach.
It means Florida organizations should not treat HIPAA as the only framework relevant to website data, vendor security, and incident response.
FIPA and HIPAA use different definitions, scopes, duties, and enforcement structures.
A Florida practice may face overlapping questions involving:
The complete comparison belongs on a dedicated cluster page: FIPA vs. HIPAA: What Florida Practices Need to Know.
Keeping that analysis separate reduces keyword cannibalization. This page owns the GA4 question, the FIPA article owns the Florida-versus-federal comparison, the server-side article owns the technical implementation, and the HIPAA Compliance in 2026 pillar remains the broad compliance resource.
Florida law generally requires notice to the relevant state department for a breach affecting 500 or more Florida residents as quickly as practicable and no later than 30 days after determining that a breach occurred or having reason to believe one occurred.
The statute also generally requires a third-party agent to notify the covered entity within 10 days after determining that a breach occurred or having reason to believe one occurred. Certain notification violations can result in civil penalties of up to $500,000 per breach.
For a Florida medical practice, documentation matters.
If a tracking problem is discovered, the organization needs to determine:
A vague tag inventory will not answer those questions.
A reliable audit begins with the live website.
Tag plans, privacy policies, and vendor dashboards describe what people believe the website does.
Network requests show what it actually does.
Our review starts with what fires in the browser, not what the implementation document says should fire.
The first pass should identify:
The audit should cover the entire website, not only the homepage.
Medical websites often behave differently across:
A tag may be absent from the global template and still be loaded through an embedded form, landing-page builder, chat widget, or scheduling tool.
Each conversion flow should be tested with controlled sample data.
The auditor should inspect what happens:
Free-text fields deserve special attention. They can contain symptoms, medications, diagnoses, procedure interests, mental-health details, pregnancy information, photographs, and other sensitive content.
One unsafe mapping can copy that information into:
The audit should follow the information beyond the browser.
For every destination, document:
| Question | Why it matters |
|---|---|
| What does the vendor receive? | Shows whether PHI or other sensitive information is involved |
| Why does it receive the data? | Defines the business purpose |
| Does the vendor sign a BAA? | Addresses contractual requirements when applicable |
| Where is the data stored? | Supports security and access review |
| Who can access it? | Identifies internal and vendor exposure |
| Is it forwarded elsewhere? | Finds hidden downstream disclosures |
| How long is it retained? | Supports minimization and lifecycle controls |
| Can fields be restricted? | Shows whether a safer configuration is possible |
The contract review should match the technical implementation.
A BAA with one vendor does not cover a separate script sending the same information to another destination.
A defensible implementation needs a written measurement specification.
For every approved event, document:
That specification becomes the reference point when the practice launches a campaign, replaces a form, changes its CRM, or gives another agency access to Google Tag Manager.
HHS says regulated organizations should include tracking technologies in their risk-analysis and risk-management processes. OCR investigations may also examine technical evidence about how tracking tools were configured and used.
Documentation is not paperwork added after the technical work.
It is part of controlling the system.
| Check | Safer position | Risk signal |
|---|---|---|
| Google BAA | No PHI is sent to GA4 | Team assumes Analytics is covered by a BAA |
| Page classification | Tags run only on reviewed pages | GA4 fires across the entire site |
| Patient portals | No GA4 or ad tracking | Third-party tags load before or after login |
| Forms | Sensitive fields stay in approved systems | Form values reach analytics or ad platforms |
| URLs | No identifiers or medical details | Email, procedure, patient, or appointment data appears |
| Event names | Neutral, approved taxonomy | Events reveal diagnosis or treatment intent |
| Data redaction | Secondary safeguard | Main method for preventing PHI collection |
| Server-side routing | Allowlisted fields only | Complete browser payload is forwarded |
| Meta Pixel | Reviewed separately | Assumed safe because GA4 was removed |
| CRM | Appropriate controls and agreements | Marketing CRM receives unreviewed patient data |
| Offline conversions | Approved, non-PHI signals | Patient outcomes are matched to ad identifiers |
| Consent | Tags respect consent controls | Cookie banner is treated as HIPAA authorization |
| BAAs | Every relevant vendor is reviewed | BAA status is assumed from marketing claims |
| Auditing | Live requests are tested regularly | Team reviews only tag-manager settings |
| Change control | New tags require approval | Vendors or agencies can publish without review |
| Florida response | FIPA duties are documented | Only federal breach duties are considered |
A practice that cannot answer these questions should pause before expanding its tracking setup.
More data is not automatically better marketing.
Uncontrolled data often creates weaker governance, noisier reporting, and greater risk at the same time.
We would not start by opening the GA4 Admin screen.
We would start with the event.
What does it reveal? Does it include an identifier? Is it connected to a procedure, appointment, diagnosis, treatment interest, payment, or patient relationship? Which system receives it first? Is that vendor permitted to receive the information? What happens before the event reaches Google?
Then we would inspect the surrounding stack.
A GA4 event can look clean while a Meta request, embedded form, scheduling widget, call-tracking script, or CRM handoff exposes the sensitive information.
That is why a tag-by-tag fix usually underperforms a complete data-flow audit.
The practical answer is straightforward:
GA4 is not a HIPAA-compliant destination for PHI. A medical practice may keep limited analytics only where its implementation prevents PHI from being disclosed to Google.
Server-side tracking may help create that separation. Data redaction may provide another safeguard. Consent management may control when tags fire. BAAs may govern vendors that legitimately need access to PHI.
None of those controls works alone.
Before another event is sent to GA4, the practice should know exactly what the event contains, where it travels, what is removed, and which agreement governs every vendor that touches it.
Request a HIPAAdvisor tracking audit to review GA4, Meta Pixel, forms, scheduling tools, CRM integrations, and patient-facing conversion flows.
Because in healthcare, “we did not mean to collect that” is not a data strategy.
No. Google states that it does not offer Business Associate Agreements for Google Analytics. HIPAA-regulated organizations should prevent PHI from reaching GA4 rather than relying on a contract that is not available.
Google Tag Manager is a deployment tool, not a HIPAA-compliance designation.
Its risk depends on the tags, triggers, variables, destinations, and information configured through it. A browser or server container that forwards PHI to an unauthorized destination does not become safe because GTM delivered the event.
No.
Server-side tracking can help block, minimize, transform, or de-identify information before it reaches GA4. It does not change Google Analytics into a HIPAA-compliant service.
The server environment, vendor relationship, BAAs, filtering rules, access controls, and downstream destinations still need to be reviewed.
Sometimes, but not simply because the page is public.
HHS explains that many unauthenticated pages may not involve PHI when tracking technologies do not access information related to an individual’s health, healthcare, or payment. Appointment pages, symptom tools, portal registration screens, and other healthcare interactions can create a different risk.
Each page and event should be evaluated based on what it actually transmits.
A medical practice should not send identifiable appointment information or patient details to GA4.
A limited, appropriately de-identified conversion signal may be possible through a controlled architecture, but the design should be reviewed before implementation, especially when the event will also be shared with Google Ads or another advertising platform.
No.
IP-related controls do not remove medical context, revealing URLs, event parameters, device identifiers, CRM connections, or other information that may be associated with a person’s healthcare activity.
The entire payload and disclosure path matter.
The more useful question is whether Meta Pixel receives PHI from the practice’s website or app.
A pixel may receive page context, identifiers, custom events, URLs, and conversion activity. If that information identifies a person and relates to healthcare, the organization must determine whether the disclosure is permitted.
Removing GA4 while leaving an unsafe Meta implementation in place does not solve the broader tracking problem.
No.
HHS states that a website banner asking users to accept or reject cookies does not constitute a valid HIPAA authorization. A consent management platform may control tag behavior, but it does not replace a required BAA, a permitted disclosure, or a HIPAA-compliant authorization.
Potentially, depending on how the data is created, whether the de-identification method is sufficient, and whether the signal can be linked back to an individual.
The critical point is that PHI should not be sent to the advertising platform and cleaned later. Filtering or de-identification must occur before the downstream disclosure.
Start with the areas most likely to contain identifiable healthcare activity:
The review should also document how HIPAA and Florida breach-response obligations would apply if an unauthorized disclosure were discovered.
Call Growth Marketing Studios today or book a 20-minute assessment. We will map what actually leaves your website, flag where GA4 and Meta Pixel create HIPAA exposure, and design a measurement architecture your compliance officer can defend.
Let’s Turn Patient Interest Into Booked Surgeries
Tell us where your clinic is today, and where you want it to be. We’ll build a revenue plan that cuts spam by up to 92%, sends only pre-qualified prospects to your coordinators (often lifting monthly sales by up to 76%), keeps deposit patients engaged for 12 months (driving ~75% more long-tail closes), and brings more post-op patients back (~22% repeat procedures). Our team deploys compliant automation across Aesthetix CRM, GoHighLevel, or your existing Medical CRM for Doctors, Surgeons & Healthcare, without adding busywork. Share a few details and we’ll show exactly which leaks to fix first and how this can pay for itself in a quarter.
Message us
support@growthmarketingstudios.com